Status:
NOT_YET_RECRUITING
Cutting-edge IMAGING Technologies to Improve the SAFEty and the Sustainability of LUNG Cancer Screening and the Accuracy of Non-invasive Lung Nodules Characterization
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Lung Cancer
Eligibility:
All Genders
18-100 years
Brief Summary
Low-dose computed tomography (LDCT) is used in individuals at high risk of developing lung cancer (smokers over 50 years of age), as it allows for the identification of pulmonary nodules, which, in a ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Indication to first lung cancer screening with LDCT according to international guidelines
- Indication to repeated lung cancer screening with LDCT according to international guidelines
Exclusion
- Age \< 18 years
- contraindication to MRI
- presence of metallic implants likely to hamper MRI image quality
- inability to hold breath for 15-20 seconds
- claustrophobia
- refusal to participate in the study
Key Trial Info
Start Date :
June 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2028
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06963515
Start Date
June 20 2025
End Date
June 20 2028
Last Update
May 9 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.